source
- FDA rejects Capricor’s Duchenne cell therapy after trials show no benefitThe Food and Drug Administration announced that it is rejecting deramiocel, a cell therapy for Duchenne muscular dystrophy developed by Capricor Therapeutics. The treatment was aimed at teenage an…
- Greenwich Rx voluntarily recalls compounded sterile products over sterility concernsGreenwich Rx, a 503A compounding pharmacy based in Tomball, Texas, announced a voluntary nationwide recall of certain compounded sterile product lots that are still within their beyond-use dates.…